The VERTEX 80/80v optics design allows PEAK flexibility and PEAK instrument performance at the same time. The unique Bruker Optics DigiTect ™ technology ensures PEAK signal-to-noise ratio ...

VRTX to report Q3 earnings, expected EPS $4.14 and $2.72B in revenue. Cramer calls it a buy, analysts see 22% upside. Stock ...

Chinese module manufacturer Trina Solar has achieved a 25.9% cell efficiency for a bifacial i-TOPCON solar cell.

In its upcoming report, Vertex Pharmaceuticals (VRTX ... trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings ...

Trinasolar has recently reached a significant milestone, delivering more than 1 GW of its Vertex N 720W series modules to the ...

Vertex Pharmaceuticals again raised its full-year outlook after posting earnings and revenue growth in the third quarter. The biotechnology company on Monday posted a quarterly net profit of $1.05 ...

Vertex also reported a steady increase in its R&D and SG&A expenses, reflecting its aggressive investment in pipeline ...

This robust design ensures the longevity of modules, enabling stable performance even in harsh environmental conditions. Innovative encapsulation technology for diverse applications The Vertex S+ ...

If we use assume a 5-year timeline until Vertex reaches this figure, which, I believe, is reasonable given past performance and growth, that represents a CAGR of 6.83%, as seen in the calculations ...

Vertex Pharmaceuticals Inc. (VRTX) released a profit for its third quarter that increased from the same period last year and beat ...

Earnings per Share (EPS): Vertex's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.03. Debt Management: With a high debt-to-equity ratio ...

“With this key asset shift safely executed, our focus continues on further optimization of the business in pursuit of sustained performance and longer-term growth.” Vertex said the conversion ...